REQUEST A DEMO
Total
USD $0.00
Search more companies

Saramed Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Saramed Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Saramed Sdn. Bhd. is an enterprise in Malaysia, with the main office in Kuching. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was first established on June 27, 2013. The latest financial highlights indicate a net sales revenue increase of 35.9% in 2022. Its’ total assets recorded a growth of 77.26%. In 2022, Saramed Sdn. Bhd.’s net profit margin decreased by 9.19%.

Headquarters
No. 313, Sl 35, Lot 1207,, Smi Industrial Park, Ph 4, Jalan Bako
Kuching; Sarawak; Postal Code: 93050

Contact Details: Purchase the Saramed Sdn. Bhd. report to view the information.

Website: http://www.mediscientx.com/

Basic Information
Outstanding Shares:
Purchase the Saramed Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Saramed Sdn. Bhd. report to view the information.
Incorporation Date:
June 27, 2013
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Saramed Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
35.9%
Total operating revenue
35.9%
Operating profit (EBIT)
-70.78%
EBITDA
-67.07%
Net Profit (Loss) for the Period
-70.85%
Total assets
77.26%
Total equity
17.9%
Operating Profit Margin (ROS)
-11.75%
Net Profit Margin
-9.19%
Return on Equity (ROE)
-46.23%
Debt to Equity Ratio
81.6%
Quick Ratio
-0.21%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?